Chronic Inflammatory Rheumatic DiseasesIMAG'RICNCT07170826
Evaluation of a Therapeutic Education Program on Self-image in Patients With Chronic Inflammatory Rheumatic Diseases
An observational study of Chronic Inflammatory Rheumatic Diseases, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
Chronic inflammatory rheumatic diseases (CIRD), like all chronic somatic disease, can impair self-esteem and self-image in affected individuals. Numerous studies conducted in this population have confirmed this fact. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Inflammatory Rheumatic Diseases
- What is being tested?
- Self questionnaire and interview
- How many people
- 60 participants
- Where
- 1 siteFrance
- Study dates
- 12 Jun 2026to Jun 2029
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The target population will consist of patients with RIC (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis) participating in the ETP programme
Who may be able to join
- Age ≥ 18 years
- Suffering from chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis)
- Having agreed to follow the therapeutic education programme offered by the department as part of routine care
- Not opposed to participating in the research
Who cannot join
- People who do not speak or read French
- Current pregnancy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Marie Laure TOURNEUR, Therapeutic education nurse contact
Aline DECHANET, Project advisor contact
France1 site, 1 recruiting
- Recruiting
Hôpital Cochin - Service de rhumatologie -27 rue du Faubourg St Jacques
Paris, Île-de-France Region, 75014
Marie Laure TOURNEUR, 01 58 41 26 58 ext. +33, marie-laure.tourneur@aphp.fr
About this study
Chronic inflammatory rheumatic diseases (CIRD), like all chronic somatic disease, can impair self-esteem and self-image in affected individuals. Numerous studies conducted in this population have confirmed this fact. Therapeutic patient education (TPE) programs aim to help patients acquire self-care and adaptive skills. However, there is a near-total absence of workshops specifically dedicated to self-image in TPE programs for CIRD. Such educational interventions have shown their effectiveness in contexts such as cancer and obesity. Our study aims to evaluate their effectiveness for patients with CIR.
Read the detailed description
A chronic disease is a long-term, progressive illness that affects the daily life of the person affected. The onset of the disease is a major upheaval, a moment of rupture between a before and an after. Physical functions and appearance can be altered by the disease (deformities, stiffness… in the case of rheumatic diseases) and by treatments.
According to Schilder, body image is "the way our body appears to ourselves." It can be defined as the set of perceptions, emotions, and thoughts related to appearance. It consists of perceptions but also of representations and feelings, which are built and evolve throughout the individual's experience. It is not limited to physical appearance and properties. It is the foundation of identity.
The disease affects the body, but also has an impact on self-perception, self-esteem, and even identity.
The literature highlights the importance of using qualitative research in addition to quantitative methods to grasp the full complexity of body image.
Despite the progress and effectiveness of treatments, recent studies showed that patients with chronic inflammatory rheumatic diseases (CIRD) have an unsatisfactory, disturbed body image. Literature data also reveal that self-esteem and quality of life in this population are lower than in the general population.
Most studies focused on the consequences of the disease, and very few on the actions taken to address these difficulties encountered by patients, even though such actions are recommended.
Therapeutic patient education (TPE) is support offered to the patient and their relatives so they can take ownership of their disease. TPE is a comprehensive approach that meets the patient's needs and aims to maintain and/or improve quality of life with the illness.
Most therapeutic education workshops related to self-image are proposed in the context of cancer, psychiatric disorders, or obesity. Body image is rarely the direct subject of a workshop in programs aimed at patients with CIRD.
A few studies on the impact of image consulting workshops have been conducted in oncology, but very few in the context of other diseases, including rheumatic conditions. Existing studies show an improvement in self-image, self-esteem, and quality of life after educational interventions, thus a real benefit for patients.
- Conditions
- Chronic Inflammatory Rheumatic Diseases
- Being tested
- Self questionnaire, interview
- Keywords
- Chronic Inflammatory Rheumatic diseases, Therapeutic patient education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self questionnaireOther
Rosenberg Scale, SF36, MBRSQ
interviewOther
Semi-structured individual interviews
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate a therapeutic patient education intervention focused on self-image in patients with chronic inflammatory rheumatic diseases
Multidimensional Body-Self Relations Questionnaire (MBSRQ)
Measured: 3 months following completion of the 'self-image' module
Secondary outcomes (4)
To evaluate a therapeutic patient education intervention on each domain of self-image
Measurement of each subscale of the Multidimensional Body-Self Relations Questionnaire (MBSRQ)
Measured: 3 months following completion of the 'self-image' module
To evaluate a therapeutic patient education intervention focused on self-image in relation to self-esteem.
Rosenberg Self-Esteem Scale before participation : min = 10, max=40
Measured: 3 months following completion of the 'self-image' module
To evaluate a therapeutic patient education intervention focused on self-image in relation to quality of life.
Measurement of the quality of life score using the SF-36 questionnaire
Measured: 3 months following completion of the 'self-image' module
To explore body image in patients after participating in therapeutic education workshops on self-image.
Data from individual qualitative interviews (inductive approach).
Measured: 4 months following completion of the 'self-image' module
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Sep 2025
- Study start12 Jun 2026
- Primary completionMar 2029 (estimated)
- Study completionJun 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Inflammatory Rheumatic DiseasesStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- URC-CIC Paris Descartes Necker Cochin
- Responsible party
- Sponsor
- Investigators
- Marie Laure TOURNEUR, Marie Laure, Principal investigator, AP-HP - Hôpital Cochin - Service de rhumatologie.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07170826
- Sponsor's protocol ID
- APHP250978
- Other IDs
- IDRCB
- Acronym
- IMAG'RIC
- Status last verified
- Oct 2026
- First submitted
- 28 Aug 2025
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No